Prescription drug use during pregnancy in France: a study from the national health insurance permanent sample.

about

Development of an algorithm to identify pregnancy episodes and related outcomes in health care claims databases: An application to antiepileptic drug use in 4.9 million pregnant women in France

P2860

Q57259547-68372D61-FE07-4BFC-99C7-14949B544F9D

P2860

Prescription drug use during pregnancy in France: a study from the national health insurance permanent sample.

Item

http://www.wikidata.org/entity/Q40113622

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Prescription drug use during p ...... th insurance permanent sample.

@en

type

Item

label

Prescription drug use during p ...... th insurance permanent sample.

@en

prefLabel

Prescription drug use during p ...... th insurance permanent sample.

@en

P1476

Prescription drug use during p ...... th insurance permanent sample.

@en

P2093

Pascale Tubert-Bitter

http://www.w3.org/2001/XMLSchema#string

Romain Demailly

http://www.w3.org/2001/XMLSchema#string

P2860

Drugs associated with teratogenic mechanisms. Part II: a literature review of the evidence on human risks

Thalidomide-induced teratogenesis: history and mechanisms

[Quality of perinatal statistics from hospital discharge data: comparison with civil registration and the 2010 National Perinatal Survey].

Actual Use of Medications Prescribed During Pregnancy: A Cross-Sectional Study Using Data from a Population-Based Congenital Anomaly Registry.

Pattern of drug use during the first trimester among Chinese women: data from a population-based cohort study.

ABO and Rhesus blood groups and risk of endometriosis in a French Caucasian population of 633 patients living in the same geographic area.

Major congenital malformations after first-trimester exposure to ACE inhibitors.

Drug use during pregnancy in Sweden - assessed by the Prescribed Drug Register and the Medical Birth Register.

Teratogenic effects of thalidomide: molecular mechanisms.

Fetopathy associated with exposure to angiotensin converting enzyme inhibitors and angiotensin receptor antagonists.

P304

1126-1134

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/PDS.4265

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Ismaïl Ahmed

Catherine Quantin

Sylvie Escolano

Pascale Tubert-Bitter

Romain Demailly

P577

2017-07-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28758270

http://www.w3.org/2001/XMLSchema#string

Prescription drug use during pregnancy in France: a study from the national health insurance permanent sample.

about

P2860

P2860

Prescription drug use during pregnancy in France: a study from the national health insurance permanent sample.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698